Gilead (GILD) announced that the FDA has accepted its new drug application submissions for lenacapavir, the company’s twice-yearly injectable HIV-1 capsid inhibitor-for the prevention of HIV as ...

Supercomputer simulations have revealed how changes in the shape of the HIV-1 capsid protein may help the virus squeeze its inner core into the host cell's nuclear membrane. The findings ...

And there are many places that will stretch their dough into the shape of your love. Bella Napoli in Schaumburg is serving up a 12-inch heart-shaped, woodfired pizza all month, as well as dinner ...